TotalMarketCap

Royalty Pharma

RPRXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$32.580 B

$56.66 -0.88%

Close of 6 Oct 2026

As of 6 Oct 2026, Royalty Pharma (RPRX) has a market capitalization of $32.6B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$2.38B

#1047 by revenue

Earnings

$770.9M

#471 by earnings

Shares outstanding

557,352,000

Latest filing cover page

P/E ratio

42.3

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →
  1. #16Teva Pharmaceutical IndustriesTEVA$46.2B
  2. #17BeOne MedicinesONC$41.1B
  3. #18Royalty PharmaRPRX$32.6B
  4. #19ZoetisZTS$29.5B
  5. #20Alnylam PharmaceuticalsALNY$29.4B

What if Royalty Pharma were worth as much as…

Open the what-if tool →

Gold $28.8T

$50,140.61

Per share 885× higher

Bitcoin $1.68T

$2,927.13

Per share 51.7× higher

Nvidia $5.76T

$10,013.01

Per share 177× higher

Or at a round number

$50.0B$100.0B$200.0B$500.0B

Where these numbers come from

Share counts and financials for Royalty Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 7 Oct 2026. Read the methodology.